Welcome to our dedicated page for Leonardo DRS SEC filings (Ticker: DRS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Leonardo DRS, Inc. (Nasdaq: DRS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Leonardo DRS is a defense technology company headquartered in Arlington, Virginia, with common stock registered under Section 12(b) of the Exchange Act and listed on The Nasdaq Stock Market LLC under the symbol DRS.
Through this page, users can review Form 10-K annual reports and Form 10-Q quarterly reports, which describe the company’s two primary segments, Advanced Sensing and Computing and Integrated Mission Systems, along with risk factors, contract information and financial results. Form 8-K current reports document material events such as leadership transitions, board changes, earnings releases and other significant corporate developments, including updates to executive employment agreements and conference call announcements.
Investors interested in ownership and governance details can also look for proxy statements and related filings that discuss board composition and committee responsibilities. In addition, Form 4 insider transaction reports, when available, show purchases and sales of DRS common stock by directors, officers and other insiders.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, helping readers quickly understand segment performance, major contracts in areas like advanced sensing, network computing, force protection, and electric power and propulsion, and notable changes in leadership or governance. Real-time updates from EDGAR ensure that new Leonardo DRS filings, including earnings-related 8-Ks and other disclosures, are added as they become available, giving users a structured view of the company’s regulatory history and ongoing reporting obligations.
Leonardo DRS, Inc. President and CEO John Baylouny reported multiple equity compensation transactions on April 1, 2026. He exercised or converted performance and time-based restricted stock units into a total of 26,960 shares of common stock and received additional stock awards as part of his compensation.
To cover tax obligations, 42,016 shares of common stock were withheld by the company at prices around $45.85 per share, which is a tax-withholding mechanism rather than an open-market sale. After these exercises, awards, and withholdings, he directly holds 158,906 shares of Leonardo DRS common stock.
Leonardo DRS, Inc. director Frances F. Townsend exercised restricted stock units into common shares as part of equity compensation. On April 1, 2026, 1,006 RSUs converted into 1,006 shares of common stock at a stated price of $0.00 per share.
Following the transaction, Townsend directly held 31,326 shares of common stock and 3,019 RSUs. The RSUs were granted under the company’s 2022 Omnibus Equity Compensation Plan and vest quarterly in 2026, contingent on continued service on the Board of Directors.
Leonardo DRS EVP and COO Sally Wallace reported multiple equity compensation transactions and an open-market sale of company stock. On April 2, 2026, she sold 28,960 shares of common stock at a weighted average price of $46.35 per share under a pre-arranged Rule 10b5-1 trading plan, and now directly holds 58,353 shares of common stock.
On April 1, 2026, previously granted performance restricted stock units (PRSUs) and other restricted stock units (RSUs) vested and were converted into common stock, and additional stock awards were granted under the company’s 2022 Omnibus Equity Compensation Plan. In connection with these vestings, the issuer withheld shares to cover tax withholding requirements, which are reported as dispositions but are not open-market sales.
Jeffery Reuben III reported acquisition or exercise transactions in this Form 4 filing.
Leonardo DRS director Jeffery Reuben III received a grant of 649 restricted stock units (RSUs) tied to company common stock. The RSUs were awarded on April 1, 2026 under the 2022 Omnibus Equity Compensation Plan and will vest in full on June 4, 2026, if he continues serving on the board.
Each RSU represents a contingent right to receive one share of Leonardo DRS, Inc. common stock. Following this grant, his reported derivative holdings from this award total 649 RSUs, reflecting standard equity-based director compensation rather than an open-market stock purchase or sale.
Leonardo DRS, Inc. is asking stockholders to elect nine directors, approve executive pay on an advisory basis, and ratify Ernst & Young as auditor at its virtual 2026 annual meeting. The company also highlights a planned leadership transition, with William J. Lynn III retiring as Chairman and CEO at the end of 2025 and John A. Baylouny becoming President and CEO and joining the Board on January 1, 2026, while Frances F. Townsend becomes Board Chair.
The proxy describes strong 2025 performance, including a 13% year-over-year revenue increase, $4.2 billion in bookings, a 1.2x book‑to‑bill ratio, $8.4 billion in backlog, 12.4% adjusted EBITDA margin, 19% free cash flow growth to $227 million, and 24% growth in adjusted diluted EPS to $1.15. Executive compensation is positioned as pay‑for‑performance, with most value in variable and equity incentives tied to adjusted EBITDA, free cash flow, bookings, revenue, and long‑term stock performance.
Sally Wallace reported an intended sale of 28,960 shares of Common stock under Rule 144. The filing lists the shares as Restricted Stock Vesting with an Issuer designation dated 04/01/2026. The filing also shows a prior sale of 1,300 shares on 01/05/2026 for $45,721.00. Shares outstanding were 265,846,193 as of 04/02/2026.
Mark Dorfman reported proposed resale activity in a Form 144 covering Common stock, including a listed block of 4,659 shares tied to restricted stock vesting dated 04/01/2025. The filing also lists prior sales of 7,680 shares on 01/05/2026 for $284,160 and 10,014 shares on 03/16/2026 for $453,333.78.
DRS filing Form 144 notifies a proposed sale of 7,071 shares of Common Stock tied to restricted stock vesting on 04/01/2025. The filing also records recent dispositions by Michael Dippold of 10,588 shares on 01/05/2026 and 16,330 shares on 03/16/2026, with proceeds reported as $391,756.00 and $739,259.10 respectively.
Leonardo DRS, Inc. director Jeffery Reuben III has filed an initial Form 3, which is the standard statement of beneficial ownership for company insiders. In this filing, he is identified as a director, and the data provided does not show any reportable transactions or derivative positions.
Leonardo DRS, Inc. executive vice president and CFO Michael Dippold sold 16,330 shares of common stock in an open‑market transaction at $45.27 per share. The sale was carried out under a pre‑arranged Rule 10b5‑1 trading plan adopted on June 13, 2025. After this transaction, he directly held 26,622 shares of Leonardo DRS common stock.